Exonate is a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases which may lead to vision loss.
Our lead asset, EXN407, has the potential to be the first topical treatment for retinal vascular diseases, including diabetic retinopathy and diabetic macular oedema. The asset met all endpoints and displayed encouraging signals of efficacy in diabetic patients with retinal eye disease (diabetic macular oedema) in a Phase Ib/IIa trial.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Wtl Moorfield Road, Duxford,cambridgeshire Cb22 4ps,united Kingdom
- Phone
- 01223 734710
- in****@****ate.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- exonate.com
- Keywords
- Paris.
- HQ
- Duxford, Cambridgeshire
Exonate Limited Questions
Exonate Limited's helpline number is 01223 734710
Exonate Limited's website is exonate.com
Exonate Limited's LinkedIn profile is https://uk.linkedin.com/company/exonate-limited
Exonate Limited has
15 employees.
View email and phone details for 15
employees at Exonate Limited.
Exonate Limited's industry is
Pharmaceutical Manufacturing
Exonate Limited's top competitors are
Arecor Therapeutics,
Myopiaai,
Isomab Ltd,
Bioserenity,
Panakeia,
Pledg,
Andzonbio,
Oculis,
Tetris Pharma Limited,
Notal Vision.
Exonate Limited's support email address is info@exonate.com
Exonate Limited's categories are Pharmaceutical Manufacturing
Exonate Limited's founding year is 2013
